Zhernakova J.V., Chazova I.E., Blinova N.V. The possibilities of angiotensin receptor blocker azilsartan medoxomil and its combination with chlortalidone in cardiovascular risk decrease in patients with obesity, metabolic syndrome and diabetes mellitus. Systemic Hypertension. 2019;16(3):36-42. (In Russ.) https://doi.org/10.26442/2075082X.2019.3.190467
Email this article (Login required)
Email the author (Login required) OOO InterMedservice
Address: 121069, Russia, Moscow, Stolovy Lane, 6
Tel.: +7 (985) 763-98-00
e-mail: og@intermed.services
The media outlet is registered with the Federal Service for Supervision of Communications, Information Technology, and Mass Media (Roskomnadzor). Registration number and date of the decision on media registration: series EL No. FS 77 - 83918 dated 12.09.2022.
16+
Processing of personal data
